)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals (EYPT) investor relations material
EyePoint Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Executive summary
Annual meeting scheduled for June 18, 2026, to be held virtually at 9:00 A.M. Eastern Time.
Proxy materials and annual report for the year ended December 31, 2025, are available online for review and voting.
Shareholders are encouraged to vote online or request paper copies of proxy materials by June 8, 2026.
Voting matters and shareholder proposals
Election of eight directors, with the board recommending a vote for all nominees.
Approval of Amendment No. 3 to the 2023 Long-Term Incentive Plan to increase authorized shares by 4,900,000.
Advisory vote on executive compensation for named executive officers.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting for all eight director nominees listed for election.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from EyePoint Pharmaceuticals
- Phase III DME and wet AMD trials advance, aiming for major market impact with novel sustained-release therapy.EYPT
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - DURAVYU advances in Phase 3 for wet AMD and DME, aiming for first-in-class market entry.EYPTCorporate presentation28 Apr 2026
- Shareholders to vote on board elections, equity plan, executive pay, and auditor ratification.EYPTProxy filing27 Apr 2026
- DURAVYU phase III trials show strong progress, safety, and reduced treatment burden, with key data due soon.EYPTRBC Capital Markets Virtual Ophthalmology Conference25 Mar 2026
- DURAVYU's pivotal Phase III trials progress, with strong cash reserves funding operations into 2027.EYPTQ4 20254 Mar 2026
- DURAVYU advances as a first-in-class, six-month sustained TKI for major retinal diseases.EYPTInvestor presentation3 Mar 2026
- Pivotal wet AMD and DME trials advance, with DURAVYU targeting six-month dosing and strong safety.EYPTGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- DURAVYU advances to global Phase 3 after strong efficacy, safety, and reduced burden in wet AMD.EYPTR&D Day 20243 Feb 2026
- DURAVYU achieved non-inferiority in wet AMD Phase 2, with Phase 3 trials starting in H2 2024.EYPTGoldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026
Next EyePoint Pharmaceuticals earnings date
Q1 20266 May, 2026
EyePoint Pharmaceuticals
Next EyePoint Pharmaceuticals earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage